Nrg-Bn001- Randomized Phase II Trial Of Hypofractionated Dose-Escalated Photon Imrt Or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant And Adjuvant Temozolomide In Patients With Newly Diagnosed Glioblastoma
Posted Date: May 15, 2019
- Investigator: Jordan Kharofa
- Specialties: Cancer, Oncology
- Type of Study: Drug
The purpose of this study is to compare a different radiation therapy schedule and higher radiation dose to the standard dose of radiation therapy. All patients will receive usual chemotherapy, temozolomide.
Criteria:
To Be Eligible For This Study, Must Have A Diagnosed Glioblastoma Tumor, Age 18 Or Older, Nonpregnant/Nonbreastfeeding, No Prior Invasive Malignancy For 3 Years Minimum, No Severe, Active Comorbidities.
Keywords:
Brain Cancer, Glioblastoma, Tumor, Glioblastoma, Nrg-Bn001
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com